X Xue, YA Yang, A Zhang,
KW Fong,
J Kim, B Song… - Oncogene, 2016 - nature.com
Tamoxifen, an estrogen receptor (ER) antagonist, is the mainstay treatment of breast cancer
and the development of resistance represents a major obstacle for a cure. Although long …